We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+42.81%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$924M
AUM Growth
+$54.5M
(+6.3%)
Cap. Flow
-$147M
Cap. Flow
% of AUM
-15.96%
Top 10 Holdings %
Top 10 Hldgs %
69.3%
Holding
56
New
7
Increased
7
Reduced
13
Closed
17
Top Buys
| 1 |
CRISPR Therapeutics
CRSP
|
+$57.7M |
| 2 |
Xencor
XNCR
|
+$35.6M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
+$28.4M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$24M |
| 5 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
+$17.6M |
Top Sells
| 1 |
KYNB
Kyntra Bio
KYNB
|
+$73.6M |
| 2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$44.7M |
| 3 |
Ionis Pharmaceuticals
IONS
|
+$39.2M |
| 4 |
Ascendis Pharma A/S
ASND
|
+$27.9M |
| 5 |
Assembly Biosciences
ASMB
|
+$26.4M |
Sector Composition
| 1 | Healthcare | 88.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
argenx
ARGX
$54B
| $103M | 11.15% |
825,087
| – | – |
|
2
Kura Oncology
KURA
$1B
| $87.5M | 9.48% |
5,276,753
| – | – |
|
|
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $73.3M | 7.93% |
1,000,000
+352,831
| +55% | +$24M |
|
|
4
CRISPR Therapeutics
CRSP
$5.03B
| $67.1M | 7.26% |
1,878,277
+1,669,427
| +799% | +$57.7M |
|
|
5
Xencor
XNCR
$1.11B
| $64M | 6.92% |
2,059,429
+1,070,411
| +108% | +$35.6M |
|
|
ONCE
6
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $60.2M | 6.52% |
529,000
-607,851
| -53% | -$44.7M |
|
7
Ironwood Pharmaceuticals
IRWD
$665M
| $59.5M | 6.44% |
5,250,219
-1,175,032
| -18% | -$13.1M |
|
|
DRNA
8
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $48.6M | 5.26% |
3,316,407
| – | – |
|
|
9
Ascendis Pharma A/S
ASND
$17.5B
| $42.5M | 4.6% |
360,819
-318,927
| -47% | -$27.9M |
|
|
10
Ultragenyx Pharmaceutical
RARE
$3.11B
| $34.5M | 3.74% |
+497,899
| New | +$28.4M |
|
|
MYOK
11
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $24.9M | 2.69% |
478,574
+244,193
| +104% | +$11.2M |
|
|
12
Assembly Biosciences
ASMB
$531M
| $22.7M | 2.46% |
96,133
-104,271
| -52% | -$26.4M |
|
|
EIGR
13
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $22.3M | 2.41% |
53,188
| – | – |
|
14
Dianthus Therapeutics
DNTH
$5.45B
| $21M | 2.28% |
79,862
-6,356
| -7% | -$1.1M |
|
15
Gossamer Bio
GOSS
$76.5M
| $16.7M | 1.81% |
+772,096
| New | +$16.1M |
|
|
CHMA
16
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $15.8M | 1.71% |
3,043,827
+2,664,074
| +702% | +$11.7M |
|
|
KZR
17
DELISTED
Kezar Life Sciences
KZR
| $15.2M | 1.64% |
85,647
-20,355
| -19% | -$4.01M |
|
|
HARP
18
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $12.7M | 1.37% |
+133,642
| New | +$17.6M |
|
19
Arcus Biosciences
RCUS
$3.53B
| $12.4M | 1.34% |
990,146
-233,349
| -19% | -$2.53M |
|
|
MRSN
20
DELISTED
Mersana Therapeutics
MRSN
| $12.1M | 1.31% |
+92,000
| New | +$11.6M |
|
|
RUBY
21
DELISTED
Rubius Therapeutics, Inc
RUBY
| $11.7M | 1.27% |
646,228
+54,100
| +9% | +$830K |
|
22
Rhythm Pharmaceuticals
RYTM
$7.52B
| $11M | 1.19% |
400,838
| – | – |
|
|
SURF
23
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $10.8M | 1.17% |
2,263,488
+2,160
| +0.1% | +$10.6K |
|
|
KYNB
24
Kyntra Bio
KYNB
$29.8M
| $9.15M | 0.99% |
6,735
-54,247
| -89% | -$73.6M |
|
25
Prothena Corp
PRTA
$449M
| $8.81M | 0.95% |
726,519
-111,700
| -13% | -$1.39M |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM